Adam Maeder
Stock Analyst at Piper Sandler
(3.70)
# 784
Out of 5,124 analysts
99
Total ratings
52.94%
Success rate
7.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Overweight | $135 → $165 | $92.23 | +78.90% | 17 | Dec 8, 2025 | |
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $4.60 | +95.65% | 9 | Nov 14, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4 → $5 | $7.93 | -36.95% | 2 | Nov 7, 2025 | |
| TCMD Tactile Systems Technology | Reiterates: Neutral | $14 → $20 | $29.00 | -31.03% | 4 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $90 → $95 | $85.25 | +11.44% | 17 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $566.36 | +7.71% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $2.17 | +222.58% | 8 | Aug 13, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $240.87 | +12.09% | 4 | Aug 1, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $10.42 | -4.03% | 2 | Jul 9, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $1.78 | +124.72% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $133 → $145 | $125.29 | +15.73% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $22.05 | -4.76% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.38 | +479.71% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.30 | +117.39% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $61.53 | +60.91% | 3 | May 5, 2022 |
Inspire Medical Systems
Dec 8, 2025
Maintains: Overweight
Price Target: $135 → $165
Current: $92.23
Upside: +78.90%
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $4.60
Upside: +95.65%
Sight Sciences
Nov 7, 2025
Maintains: Neutral
Price Target: $4 → $5
Current: $7.93
Upside: -36.95%
Tactile Systems Technology
Nov 4, 2025
Reiterates: Neutral
Price Target: $14 → $20
Current: $29.00
Upside: -31.03%
Edwards Lifesciences
Oct 31, 2025
Reiterates: Overweight
Price Target: $90 → $95
Current: $85.25
Upside: +11.44%
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $566.36
Upside: +7.71%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $2.17
Upside: +222.58%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $240.87
Upside: +12.09%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $10.42
Upside: -4.03%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $1.78
Upside: +124.72%
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $125.29
Upside: +15.73%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $22.05
Upside: -4.76%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.38
Upside: +479.71%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.30
Upside: +117.39%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $61.53
Upside: +60.91%